MX
Last reporting period 30 Jun, 2024
Updated 19 Sep, 2024
Last price
—
Market cap $B
0.427
Exchange
XNAS - Nasdaq
12.6
Last period Current ratio
What is Current ratio ?
Current ratio is the company's ability to repay all its short-term liabilities with available liquid assets. The value of 1.5 is the benchmark for Eyestock Rating calculation.
See also MaxCyte
Company Analysis
MXCT valuation, rating, competitors, insights and company profile
Eyestock Rating
MXCT financial analysis by Eyestock methodology
Valuation
MXCT valuation using historical relative method
Statements
MXCT Income Statements, Balance Sheet and Cash Flow Statements
Dividends
MXCT dividend yield and annual dividend
Current ratio is the company's ability to repay all its short-term liabilities with available liquid assets. The value of 1.5 is the benchmark for Eyestock Rating calculation.
MaxCyte`s Current ratio for the last twelve months ended 2024-06-30 is 12.6
